A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting

Clinical trial NCT02413008 · COMPLETED

Trial details

NCT number: NCT02413008
Sponsor: ITF Research Pharma, S.L.U.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vaginal Atrophy

Start date: 2015-10-16
Primary completion: 2017-02-10
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.